# Alico share price today (Alico, Inc., ALCO)

> Alico, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. ALCO · Consumer Staples · Farm Products · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/alco

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $37.11 (+5.4% in a year)
- P/E: 189.7×, against its own history
- Revenue (Jun 2026): ₹0.0 B
- Profit (Jun 2026): ₹0.0 B
- Operating margin: 19.8% (+93.2 points on a year ago)
- ROE: −136%, FY25

The main question: profits are rising, but only −142% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Alico share price today? Alico, Inc.'s share price was $37.11 at the close on 3 November 2026. That is 7.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between $32 and $44, and at that close it sat 43% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 29 weeks running. Over the last 1 year the share price moved +13% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 17 April 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Alico pay? Alico, Inc. declared ₹0.05 per local share for Jun 2026, and ₹0.20 over the last four reported quarters. It reports in its home currency, and one US-listed share can stand for several local shares, so we do not set this against the dollar price or show a yield. ## Which stock lists is Alico on? Alico is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Alico profitable? Alico, Inc. earned ₹0.0 B of net profit in the Jun 2026 quarter. The full FY25 year was a loss of ₹0.1 B. That is 23.5% of the quarter's revenue. The same quarter a year earlier lost ₹0.02 B. 8 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was −₹0.1 B (−2,212.9% on the year before). This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## How much revenue does Alico make, and is it growing? Alico, Inc. reported ₹0.0 B of revenue in the Jun 2026 quarter, +7.7% on the same quarter a year earlier. Over 4 years it has grown −20.2% a year on average. The last full year, FY25, came in at ₹0.0 B. The last four reported quarters add to ₹0.0 B. FY25 revenue was ₹0.0 B, −5.5% on the year before. Recent pace: the last four quarters grew −41.4% on average, against −20.2% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −61.4%, against −39.3% a year over the last 8 quarters (rolling over). This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## How much of its sales does Alico keep? Alico, Inc.'s operating margin was 19.8% in the Jun 2026 quarter, 93.2 percentage points higher than the same quarter a year ago. Across 5 years it has been between −60.7% and 13.3%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +93.2 percentage points on the year while gross margin changed +84.0 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Alico's profit turning into cash? Over the last 3 years Alico, Inc.'s operations used more cash than they brought in, so cash conversion was −142%, a gap worth watching. In FY25 it brought in ₹0.0 B of operating cash against −₹0.1 B of profit. After ₹0.0 B of spending on assets, ₹0.0 B was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: it spends almost nothing on new assets, so the cash goes on running the business. The next section shows the spending figures. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## Where does Alico's cash go? Alico, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent ₹0.0 B on assets over the last 3 years. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: ₹0.0 B over the last 3 years. In short: almost nothing is being spent on new assets, so the cash goes on running the business. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## What is Alico's P/E ratio, and how does it compare with its own history? Alico, Inc.'s P/E is 189.7×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Alico business getting better or worse? Alico, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Alico earn on its capital? Alico, Inc. earned a ROE of −136% in FY25. Its return on capital used (ROIC) is left out: on sales this small it reads 96%, a number that says nothing useful about the business. It comes from a −334.3% net margin and 0.22× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −334.3% net margin × 0.22× asset turnover × 1.87× leverage (assets divided by equity) ≈ −137.5% on equity. The margin does its share; borrowing is a big part of it. ## Does Alico have too much debt? Alico, Inc. has total debt of ₹0.1 B against shareholder equity of ₹0.1 B as of Jun 2026, so its debt is 0.81× its equity. Year by year, that ratio went from 0.50 in FY21 to 0.79 in FY25. Keep that borrowing in mind when reading the returns on this page. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## What is the Alico shareholding pattern? 3.3% of Alico, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 8.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Alico from balance-sheet trouble? For Alico, Inc., the Z-score is 2.73. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.73 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Alico rank in its industry? 57.7 out of 100, rank 2 of 11 in Farm Products, with 64% of the evidence available. Alico, Inc. scores 57.7 out of 100 against the 11 companies it is compared with in Farm Products, ranking 2. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 20.5 + 18.9 + 8.5 + 9.8 = 57.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Alico compared with? Alico ranks 2 of 11 Farm Products companies on the 4-Factor Sector Score, with 57.7 out of 100. 1. [Village Farms International, Inc.](https://www.sectoralpha.in/us/stocks/vff) VFF · breaking out · Most evidence points up · 71% evidence 69.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.3/35 · Revenue 15.5% · Profit 100% · Operating margin change 5.8 points · 83% evidence Capital efficiency 14.0/25 · ROCE 9.8% · Operating margin 17.4% · 76% evidence Valuation 11.2/20 · P/E 10.7× · PEG n/a · 15% evidence Relative strength 17.3/20 · Lead over its industry 7.4% · Lead over S&P 500 -6% · 1 year -3.7% · 100% evidence · 11 of 12 weeks ahead Exact sum: 27.3 + 14 + 11.2 + 17.3 = 69.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. Alico, Inc. this page ALCO · quiet · Evidence leans up · 64% evidence 57.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue -61.4% · Profit n/a · Operating margin change 93.2 points · 62% evidence Capital efficiency 18.9/25 · ROCE 71.3% · Operating margin 19.8% · 76% evidence Valuation 8.5/20 · P/E 200.3× · PEG n/a · 15% evidence Relative strength 9.8/20 · Lead over its industry 1.5% · Lead over S&P 500 -10.3% · 1 year 12.6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 18.9 + 8.5 + 9.8 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Archer-Daniels-Midland Company](https://www.sectoralpha.in/us/stocks/adm) ADM · quiet · Evidence leans up · 81% evidence 57.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.2/35 · Revenue -0.8% · Profit 61.1% · Operating margin change 1.8 points · 83% evidence Capital efficiency 12.6/25 · ROCE 5.7% · Operating margin 4% · 76% evidence Valuation 13.5/20 · P/E 20.8× · PEG 0.55 · 65% evidence Relative strength 10.2/20 · Lead over its industry 3.7% · Lead over S&P 500 -7.7% · 1 year 23.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 21.2 + 12.6 + 13.5 + 10.2 = 57.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Adecoagro S.A.](https://www.sectoralpha.in/us/stocks/agro) AGRO · turning · Evidence leans up · 74% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.7/35 · Revenue 6.3% · Profit 42.9% · Operating margin change 16 points · 62% evidence Capital efficiency 11.7/25 · ROCE 2.6% · Operating margin 17% · 76% evidence Valuation 11.5/20 · P/E 27.5× · PEG 0.65 · 65% evidence Relative strength 8.6/20 · Lead over its industry -1% · Lead over S&P 500 -12.5% · 1 year 15.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 21.7 + 11.7 + 11.5 + 8.6 = 53.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Dole plc](https://www.sectoralpha.in/us/stocks/dole) DOLE · basing · Evidence leans up · 81% evidence 52.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue 8.3% · Profit 78.8% · Operating margin change -1.2 points · 83% evidence Capital efficiency 11.7/25 · ROCE 6.2% · Operating margin 2.7% · 76% evidence Valuation 13.8/20 · P/E 21.9× · PEG 0.22 · 65% evidence Relative strength 7.9/20 · Lead over its industry -1.9% · Lead over S&P 500 -13.7% · 1 year -0.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.3 + 11.7 + 13.8 + 7.9 = 52.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Bunge Global SA](https://www.sectoralpha.in/us/stocks/bg) BG · basing · Evidence leans down · 81% evidence 49.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.2/35 · Revenue 80.5% · Profit -26.9% · Operating margin change 1.8 points · 83% evidence Capital efficiency 14.3/25 · ROCE 7.2% · Operating margin 4.6% · 76% evidence Valuation 11.8/20 · P/E 20.6× · PEG 0.7 · 65% evidence Relative strength 3.1/20 · Lead over its industry -9% · Lead over S&P 500 -19.7% · 1 year 0% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.2 + 14.3 + 11.8 + 3.1 = 49.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Tyson Foods, Inc.](https://www.sectoralpha.in/us/stocks/tsn) TSN · turning · Evidence leans down · 71% evidence 45.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.0/35 · Revenue 2.9% · Profit -26.8% · Operating margin change -1.2 points · 83% evidence Capital efficiency 9.8/25 · ROCE 4.2% · Operating margin 2.7% · 76% evidence Valuation 9.2/20 · P/E 35.9× · PEG n/a · 15% evidence Relative strength 14.0/20 · Lead over its industry 3.8% · Lead over S&P 500 -8.6% · 1 year 8.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 12 + 9.8 + 9.2 + 14 = 45 · What this means: Relative strength against the index is -8.6%, and revenue and profit growth are weak. 8. [Cal-Maine Foods, Inc.](https://www.sectoralpha.in/us/stocks/calm) CALM · basing · Most evidence points down · 85% evidence 32.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 4.5/35 · Revenue -42.5% · Profit -95.4% · Operating margin change -41.3 points · 95% evidence Capital efficiency 8.5/25 · ROCE 0.6% · Operating margin -15.1% · 76% evidence Valuation 16.5/20 · P/E 6× · PEG 0.2 · 65% evidence Relative strength 3.0/20 · Lead over its industry -9.7% · Lead over S&P 500 -20.5% · 1 year -25.4% · 100% evidence · 1 of 12 weeks ahead Exact sum: 4.5 + 8.5 + 16.5 + 3 = 32.5 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 9. [Vital Farms, Inc.](https://www.sectoralpha.in/us/stocks/vitl) VITL · basing · Most evidence points down · 71% evidence 31.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.9/35 · Revenue 16.4% · Profit -101.9% · Operating margin change -37.1 points · 83% evidence Capital efficiency 6.1/25 · ROCE 0.1% · Operating margin -24.2% · 76% evidence Valuation 10.2/20 · P/E 21.4× · PEG n/a · 15% evidence Relative strength 5.6/20 · Lead over its industry -36.7% · Lead over S&P 500 -45.6% · 1 year -71.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 9.9 + 6.1 + 10.2 + 5.6 = 31.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. Limoneira Company LMNR · quiet · Most evidence points down · 67% evidence 27.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue -19.4% · Profit n/a · Operating margin change 4.7 points · 71% evidence Capital efficiency 4.5/25 · ROCE -10.5% · Operating margin 3.4% · 76% evidence Valuation 8.8/20 · P/E 72.9× · PEG n/a · 15% evidence Relative strength 0.9/20 · Lead over its industry -17.7% · Lead over S&P 500 -27.5% · 1 year -27.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 12.8 + 4.5 + 8.8 + 0.9 = 27 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Forafric Global PLC](https://www.sectoralpha.in/us/stocks/afri) AFRI · leader · Too little evidence to rank firmly · 39% evidence 51.5 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Farm Products](https://www.sectoralpha.in/us/sectors/farm-products), all 11 compared on one page. ## Which companies are close to Alico in size? Alico is the 11th largest of 12 Farm Products companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Dole plc, Vital Farms, Inc., Village Farms International, Inc., Forafric Global PLC and BrasilAgro - Companhia Brasileira de Propriedades Agrícolas. Just below it: Limoneira Company. ### Farm Products companies close in size

1. [Dole plc](https://www.sectoralpha.in/us/stocks/dole) $1.2 billion
2. [Vital Farms, Inc.](https://www.sectoralpha.in/us/stocks/vitl) $430 million
3. [Village Farms International, Inc.](https://www.sectoralpha.in/us/stocks/vff) $349 million
4. [Forafric Global PLC](https://www.sectoralpha.in/us/stocks/afri) $334 million
5. [BrasilAgro - Companhia Brasileira de Propriedades Agrícolas](https://www.sectoralpha.in/us/stocks/lnd) $311 million
6. Alico, Inc. $275 million
7. [Limoneira Company](https://www.sectoralpha.in/us/stocks/lmnr) $182 million

[All 12 Farm Products companies, largest first](https://www.sectoralpha.in/us/sectors/farm-products#all-companies)

### Companies close in size in other industries

1. [First Northern Community Bancorp](https://www.sectoralpha.in/us/stocks/fnrn) $279 million · Banks - Regional
2. [Ribbon Communications Inc.](https://www.sectoralpha.in/us/stocks/rbbn) $278 million · Software - Application
3. Alico, Inc. $277 million
4. [International Money Express, Inc.](https://www.sectoralpha.in/us/stocks/imxi) $277 million · Software - Infrastructure
5. [First National Corporation](https://www.sectoralpha.in/us/stocks/fxnc) $276 million · Banks - Regional

## What else do people ask about Alico? ### What were Alico's latest quarterly results? Alico, Inc. reported revenue of ₹0.0 B and net profit of ₹0.0 B for the Jun 2026 quarter. The operating margin was 19.8%, 93.2 percentage points higher than a year earlier (as of 3 November 2026). ### What is Alico's market cap? Alico, Inc.'s market capitalisation is $275 M at a stock price of $37.11. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Alico performing? Alico, Inc.'s latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 29 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Alico's stock price go up? This page does not forecast Alico, Inc.'s stock price. What it shows instead: the stock price is $37.11. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Alico in its business cycle? Alico, Inc.'s FY25 operating margin was −60.7%, against a 5-year range of −60.7% to 13.3%: the low end of its own range, which is often where recoveries start. The latest quarter was 19.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Alico story? The main question: profits are rising, but only −142% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Alico a stock worth studying right now? What the numbers show: Alico, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.